Virtual GEoPD Meeting in Milan 2020
15th International Meeting, October 15th - October 16th
-
Centro Congressi Humanitas, via Manzoni 113 Rozzano Milano
11:00 Introduction and welcome by the President and the hosts Rejko Krüger
Stefano Duga
Alessio Di Fonzo11:05 MJFF/GEoPD Monogenic PD project Christine Klein 11:30 Courage-PD: first results and future
projectsAlexis Elbaz & Manu Sharma 11:55 Can blood-derived DNA methylation studies provide clues to the cause of Parkinson’s? George Mellick 12:10 GWAS on impulse control disorders in
Parkinson’s diseaseJean-Christophe Corvol 12:35 Lunch - Students or young researchers talks Maryam Hassan
Hui Lui
Zied Landoulsi
Sinthuja Pachchek13:35 Variants in saposin D domain of prosaposin gene linked to Parkinson's diseases Yutaka Oji (on behalf of Nobutaka Hattori) 13:50 Disease trajectories in Parkinson’s disease: Insights from the Long PD and DodoNa cohorts Katerina Markopoulou 14:15 Update from Florida site Matthew Farrer 14:30 Lux-GIANT: Indian PD Initiative Sandeep Grover (on
behalf of Manu Sharma)14:45 HELP-PD in the Siberian cohort Alexey Rozhdestvensky 15:00 Coffee break 15:15 LRRK2 modifier project Thomas Courtin (on
behalf of Alexis Brice)15:30 New project proposals & discussion Rejko Krüger and All GEoPD members only -
Centro Congressi Humanitas, via Manzoni 113 Rozzano Milano
10:00 Students or young researchers talks Pauline Mencke, Katja Badanjak (Luxembourg),
Xiaoying Kang (Sweden)
Cloé Domenighetti (France)
Giada Melistaccio (Italy)
Amica Muller (South Africa)
Nicolas Casadei (Germany)
Micol Avenali (Italy)12:15 Coffee Break 12:30 Global Parkinson’s Genetics Program (GP2) Enza Maria Valente 13:00 Lunch 14:00 Global Parkinson’s Genetics Program Andrew Singleton 14:30 Discussion on GP2 initiative Lysosomal genes and Parkinson’s disease session 14:45 Clinical features of GBA-PD Christine Klein & Enza Maria
Valente15:15 The Interplay of Mitochondrial and Lysosomal Dysfunction in Parkinson’s
DiseaseDimitri Krainc 15:45 Coffee break 16:00 GBA penetrance and patient-derived models Stefano Duga and Alessio Di Fonzo 16:30 Targeted therapeutic approaches Pablo Sardi 17:00 Closing remarks Public meeting